# FDA EIR - LANXESS Corporation - August 02, 2013

Source: https://www.globalkeysolutions.net/records/eir/lanxess-corporation/e5e1aaf1-ed4e-44c7-8fa1-6121b4738582

> FDA EIR for LANXESS Corporation on August 02, 2013. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: EIR
- Company Name: LANXESS Corporation
- Inspection Date: 2013-08-02
- Product Type: Drugs
- Office Name: Seattle District Office

## Related Documents

- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/lanxess-corporation/daad3a10-e049-45f8-9741-df91a56b03b3)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/lanxess-corporation/2c78c482-be53-4dbe-962d-1997cfb013fb)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/lanxess-corporation/cc764aaf-7992-45b5-899d-76bdc57809f2)

## Related Officers

- [issuing_officer](https://www.globalkeysolutions.net/people/sunitha-k-rajaram/1a0872d4-5e7b-4690-a2be-3877aec25053)
- [issuing_officer](https://www.globalkeysolutions.net/people/carol-a-gripp/4ae9ce1f-8505-4362-a348-4cdc700c3817)

Company: https://www.globalkeysolutions.net/companies/lanxess-corporation/d4d93912-8e03-47f0-87e8-1aac96f0a44d

Office: https://www.globalkeysolutions.net/offices/seattle-district-office/9305837f-0738-4075-b444-a55e7a2b8913